MYM Announces Shares for Debt Transaction

Ad blocking detected

Thank you for visiting CanadianInsider.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Ultra Club
$500/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads
JOIN THE CLUB

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

Return to homepage

(TheNewswire)



Vancouver, British Columbia - TheNewswire - August 31, 2020 - MYM Nutraceuticals Inc. (CSE:MYM) (CNSX:MYM.CN) (OTC:MYMMF) (“MYM” or the “Company”) announces that the Company has agreed a shares for debt transaction whereby the Company issued 668,760 common shares of the Company ("Shares") at a deemed price of $0.06 per Share pursuant to certain employment and consulting agreements that contain provisions for the issuance of Shares as part of the compensation (the "Transaction").

 

All Shares issued in connection with the Transaction are subject to a minimum four-month hold period as required by Canadian securities laws. The Transaction is subject to approval of the Canadian Securities Exchange (the “CSE”).

As certain insiders participated in the Transaction, it is considered to be a "related party transaction" as defined under Multilateral Instrument 61-101 ("MI 61-101").  The transaction is exempt from the formal valuation and minority shareholder approval requirements of MI 61-101 as neither the fair market value of the securities to be distributed in the Transaction in so far as the Transaction involves the insiders, exceeds 25% of the Company's market capitalization.

The Company is also pleased to announce that Mark Forster has been reappointed as Chief Financial Officer of the Company.  Mr. Forster is a CPA-CGA registered in BC and has over 30 years of public business experience in the banking and consumer industrial markets sectors.  

About MYM Nutraceuticals Inc.

MYM is a licensed cannabis producer in Canada uniquely positioned to opportunistically acquire and/or invest in companies within the cannabis industry that are in need of capital and management support. Our senior management team is made up of experts engaged in a wide array of disciplines, able to manage all aspects of licensed cannabis production and sales. MYM wholly owns two cannabis cultivation facilities – SublimeCulture Inc in Laval, QC and Highland Grow in Antigonish, NS. The Company is actively looking to acquire complementary businesses and assets in the cannabis sector. MYM shares trade in Canada, Germany and the United States under the following symbols: (CSE: MYM) (OTC: MYMMF) (FRA:0MY) (DEU:0MY) (MUN:0MY) (STU:0MY).

ON BEHALF OF THE MYM BOARD
Michael Wiener, CEO
MYM Nutraceuticals Inc.
www.mym.ca

Investor Relations

[email protected]

Keep up to date with MYM on our social media channels:

Twitter: @mymnutra

Facebook: @mymnutra

Instagram: @mymnutra

Copyright (c) 2020 TheNewswire - All rights reserved.